A biologic signature to predict ipsilateral breast event risk at 10 years for early breast cancer

被引：0
|
作者：
Bremer, T.
Savala, J.
Leesman, G.
Warnberg, F.
Sund, M.
Wadsten, C.
Whitworth, P. W.
机构：
[1] PreludeDx, Laguna Hills, CA USA
[2] Uppsala Univ, Uppsala, Sweden
[3] Umea Univ, Umea, Sweden
[4] Nashville Breast Ctr, Nashville, TN USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P2-08-57
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-08-57
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Breast Hyperplasias, Risk Signature, and Breast Cancer
    Poola, Indira
    Yue, Qingqi
    Gillespie, John W.
    Sullivan, Peggy S.
    Aguilar-Jakthong, Josephine
    Rao, JianYu
    Shaaban, Abeer M.
    Sauter, Edward R.
    Ricci, Andrew J.
    [J]. CANCER PREVENTION RESEARCH, 2019, 12 (07) : 471 - 480
  • [2] A 10-gene signature to predict the prognosis of early-stage triple-negative breast cancer
    Kim, Chang Min
    Park, Kyong Hwa
    Yu, Yun Suk
    Kim, Ju Won
    Park, Jin Young
    Lee, Jeong Eon
    Sim, Sung Hoon
    Seo, Bo Kyoung
    Kim, Jin Kyeoung
    Lee, Eun Sook
    Park, Yeon Hee
    Kong, Sun-Young
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [3] A scoring system to predict breast cancer mortality at 5 and 10 years
    Esther Paredes-Aracil
    Antonio Palazón-Bru
    David Manuel Folgado-de la Rosa
    José Ramón Ots-Gutiérrez
    Antonio Fernando Compañ-Rosique
    Vicente Francisco Gil-Guillén
    [J]. Scientific Reports, 7
  • [4] A scoring system to predict breast cancer mortality at 5 and 10 years
    Paredes-Aracil, Esther
    Palazon-Bru, Antonio
    Manuel Folgado-de la Rosa, David
    Ramn Ots-Gutierrez, Jose
    Fernando Compan-Rosique, Antonio
    Francisco Gil-Guillen, Vicente
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [5] Evaluation of a breast cancer nomogram to predict ipsilateral breast relapse after breast-conserving therapy
    Kindts, Isabelle
    Laenen, Annouschka
    Peeters, Stephanie
    Janssen, Hilde
    Depuydt, Tom
    Neven, Patrick
    Van Limbergen, Erik
    Weltens, Caroline
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 (01) : 45 - 51
  • [6] Atorvastatin lowers breast cancer risk by reversing an early tumorigenic signature
    Foda, Mohamed Y.
    Salem, Mohamed L.
    Alakwaa, Fadhl M.
    El-khawaga, Omali Y.
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [7] Age and HER 2 Subtype Predict the Risk of Ipsilateral Breast Tumor Recurrence After Breast Conservative Therapy in Chinese Breast Cancer Patients
    Yang, Z.
    Zhang, L.
    Yu, X.
    Mei, X.
    Ma, J.
    Chen, J.
    Guo, X.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S223 - S223
  • [8] Lymphopenia as a Potential Predictor of Ipsilateral Breast Tumor Recurrence in Early Breast Cancer
    Cho, Oyeon
    Chun, Mison
    Kim, Sang Won
    Jung, Yong Sik
    Yim, Hyunee
    [J]. ANTICANCER RESEARCH, 2019, 39 (08) : 4467 - 4474
  • [9] A Metabolic Gene Signature to Predict Breast Cancer Prognosis
    Lu, Jun
    Liu, Pinbo
    Zhang, Ran
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [10] Breast conserving surgery for invasive breast cancer: Risk factors for ipsilateral breast tumor recurrences
    K. Dalberg
    A. Mattsson
    L.E. Rutqvist
    U. Johansson
    L. Riddez
    K. Sandelin
    [J]. Breast Cancer Research and Treatment, 1997, 43 : 73 - 86
12345